Inventor
Yang Feng
Inventor
Frederick, MD, US
Overview
Patents· 20 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%
C07KPeptides23%
A61KPreparations for medical, dental or toiletry purposes21%
G06FElectric digital data processing13%
G01NInvestigating or analysing materials by determining their chemical or physical properties8%
G06NComputing arrangements based on specific computational models4%
A61BDiagnosis2%
A61CDentistry2%
B82YSpecific uses or applications of nanostructures2%
G06TImage data processing or generation, in general2%
PatentTitleYear
10,810,272Method and apparatus for broadcasting search result based on artificial intelligence202010,730,941Antigen-binding proteins targeting CD56 and uses thereof202010,726,551Method for reconstructing joined part surfaces of two adjacent teeth of a 3D digital model of teeth202010,633,441Mesothelin-targeted chimeric antigen receptors and uses thereof202010,548,987Antibody-drug conjugates for targeting CD56-positive tumors202010,538,588Mesothelin-targeted chimeric antigen receptors and methods of making them20209,963,505Anti-human folate receptor beta antibodies and methods of use20189,914,773'Anti-human folate receptor beta antibodies and methods of use'20189,875,441Question recommending method, apparatus and system20189,127,056'Monospecific and bispecific human monoclonal antibodies targeting insulin-like growth factor II (IGF-II)'20159,044,457'Anti-DR4 agonist antibodies'20158,871,206'Anti-human folate receptor beta antibodies and methods of use'20148,726,232'Identification of patterns in modeling environments'20148,667,381'Block diagram change history'20148,584,088'Identification of patterns in modeling environments'20138,357,783'Human anti-mesothelin monoclonal antibodies'20138,225,276'Shared code management'20128,105,598'Human monoclonal antibodies that specifically bind IGF-II'20127,824,681'Human monoclonal antibodies that specifically bind IGF-II'20107,500,220'Shared code management'2009Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2009–2014Patents assigned to MATHWORKS INC (5)· patent assignee history
2009–2014Based in Waltham, MA, US· patent location history
2010–2020Patents assigned to US HEALTH (11)· patent assignee history
2010–2020Based in Frederick, MD, US· patent location history
2012–2015Patents assigned to FENG YANG (7)· patent assignee history
2014–2018Patents assigned to PURDUE RESEARCH FOUNDATION (3)· patent assignee history
2018Based in Shenzhen, CN· patent location history
2020Patents assigned to MEMORIAL SLOAN KETTERING CANCER CENTER (3)· patent assignee history
2020Based in Beijing, CN· patent location history
2020Based in Shanghai, CN· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| US HEALTH | 11 | 2010–2020 |
| FENG YANGself | 7 | 2012–2015 |
| MATHWORKS INC | 5 | 2009–2014 |
| MEMORIAL SLOAN KETTERING CANCER CENTER | 3 | 2020 |
| PURDUE RESEARCH FOUNDATION | 3 | 2014–2018 |
Locations
| Location | Patents | Span |
|---|---|---|
| Frederick, Maryland, US | 12 | 2010–2020 |
| Waltham, Massachusetts, US | 4 | 2009–2014 |
| Beijing, CN | 1 | 2020 |
| Shanghai, CN | 1 | 2020 |
| Shenzhen, CN | 1 | 2018 |